-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Outperform on Insulet, Raises Price Target to $200

Benzinga·11/05/2026 17:22:42
Listen to the news
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $175 to $200.